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 Abstract 
Background: Pre-flight risk assessments are currently recommended for all 
Interstitial Lung Disease (ILD) patients. Hypoxic challenge testing (HCT) can inform 
regarding the need for supplemental in-flight oxygen but variables which might 
predict the outcome of HCT and thus guide referral for assessment, are unknown.  
 
Methods: A retrospective analysis of ILD patients attending for HCT at three tertiary 
care ILD referral centres was undertaken to investigate physiological variables that 
might predict a hypoxaemic response to HCT. Concordance between HCT and 
existing predictive equations for prediction of in-flight hypoxia was also explored.  
 
Results: A total of 106 ILD patients (69 of whom (65%) had Idiopathic Pulmonary 
Fibrosis (IPF)) underwent HCT. Of these, 54 (51%) patients (of whom 37 (69%) had 
IPF) failed HCT and were recommended supplemental in-flight oxygen. Existing 
predictive equations were unable to accurately predict the outcome of HCT. ILD 
patients who failed HCT had significantly lower resting SpO2, baseline PaO2, 
reduced walking distance, FEV1, FVC and TLCO, but higher GAP index than those 
who passed HCT.  
 
Conclusions: TLCO >50% predicted and PaO2 >9.42kPa were independent 
predictors for passing HCT. Using these discriminators, a novel, practical pre-flight 
algorithm for evaluation of ILD patients is proposed.  
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Interstitial lung disease, hypoxic challenge test, Idiopathic Pulmonary Fibrosis 
 
Introduction 
Hypobaric hypoxia arises during air travel because of the inverse relationship 
between the partial pressure of oxygen and altitude, observed as a fall in total 
ambient pressure during ascent. Commercial airlines commonly cruise at 38000 feet 
to improve fuel economy, typically pressurizing air cabins to a maximum of altitude of 
8000 feet (2438m), reducing the effective altitude to which passengers are exposed1. 
This pressurisation is equivalent to breathing approximately 15% oxygen at sea level, 
but the precise cabin altitude can vary according to the aircraft design and exact 
aircraft altitude, which may be exceeded to avoid adverse weather conditions2. 
 
In healthy individuals, increased minute ventilation, heart rate and cardiac output 
compensate, such that little physiological impact is experienced by most individuals 
at typical cabin altitudes3,4. Clinical manifestations of hypobaric hypoxia include 
headache, euphoria, impairment of judgement or memory and in more severe cases 
peripheral visual field defects, unconsciousness and death5,6. 
The British Thoracic Society (BTS) currently recommends risk assessment of all 
interstitial lung disease (ILD) patients prior to air travel to predict the likelihood of 
respiratory problems and to identify those requiring supplemental in-flight oxygen3.  
Hypoxic challenge testing (HCT)7 is the method of choice to identify patients who 
might require supplemental in-flight oxygen, based on its ability to reliably identify 
patients requiring supplemental oxygen when compared to hypobaric chamber, its 
widespread availability and relative low cost8,9. Arbitrary cut-offs of PaO2 of <6.6kPa 
or SpO2 <85% are positive indicators of the need for supplemental in-flight oxygen
10. 
The evidence surrounding which ILD patients to refer for HCT is currently lacking. 
 
Predictive equations are alternatives that have been developed for use in clinical 
practice, to predict PaO2 at altitude
7, 11-15, but have been developed almost 
exclusively using patients with COPD and their role in patients with ILD has not been 
fully defined.  
The aim of this study was to explore the correlation and concordance between HCT 
and predictive equations for prediction of in-flight hypoxia in ILD patients and 
secondly to identify physiological variables that might be used to predict the outcome 
of HCT in patients with ILD. 
Methods 
This study was approved by the Health Research Authority, United Kingdom (UK) 
(Reference 17/HRA/0007). The clinical records of 106 consecutive ILD patients 
presenting to three UK secondary care ILD centres for routine HCT (between 
January 2010 and March 2017), were retrospectively analysed. All patients had an 
ILD multidisciplinary team (MDT) consensus diagnosis. Baseline demographic data, 
oxygen saturations (SpO2) using pulse oximetry and capillary ear lobe partial 
pressure of oxygen (PaO2) were collected. Spirometry, transfer factor for carbon 
monoxide (TLCO) and 6-minute walk tests (6MWT), performed according to BTS 
guidelines16 and within 6 months of the HCT, were also evaluated. The GAP index17 
(gender, age and lung physiology index) was calculated from the collated information. 
 
HCT was undertaken using the Ventimask method, whereby 100% nitrogen was 
delivered through a 40% Ventimask at a designated flow rate of 10.0 l/min, resulting 
in an equivalent inspired fraction of oxygen (FiO2) of 15% O2
18. A fall of PaO2 to 
<6.6kPa during the test indicated that the individual should be recommended 
supplemental in-flight oxygen (Failed HCT), according to BTS guidelines3.  
 
The predicted partial pressure of oxygen at altitude (PaO2 Alt) was calculated by 
applying the collated data to four published predictive equations (Supplemental 
Table 1). Supplemental in-flight oxygen requirement predictions were compared to 
the actual HCT results.      
 
Physiological variables were compared between patients requiring supplemental in-
flight oxygen, as determined by the HCT, compared to those who did not. Patients 
were either compared as a single group of ILD patients or stratified into Idiopathic 
Pulmonary Fibrosis (IPF) versus non-IPF.   
 
Statistical analyses were performed using Graphpad Prism 7.0 software (CA, USA), 
with multivariable analysis using STATA data analysis and statistical software (Texas, 
USA). The sensitivity and specificity of existing published predictive equations as 
compared to actual HCT results were calculated using a cut-off of PaO2 of <6.6kPa.  
 
Categorical variables were presented as counts, whilst continuous variables were 
presented as means +/- standard deviation (S.D.). Univariable logistic regression 
analysis was used to compare physiological variables in a) ILD patients and b) IPF 
patients referred for hypoxic challenge testing (HCT) and the outcome of HCT in a 
priori statistical analysis plan. Results were presented as Odds Ratios (OR) with 95% 
confidence intervals (CI). 
 Receiver operating characteristics (ROC) curve analyses were performed on 
correlating variables with the identification of optimum cut-off points (decision point) 
for each variable, identified using the maximum Youden’s index (J), where J max = 
Sensitivity + Specificity-1. Multivariable logistic regression analysis was performed to 
identify factors independently predicting the outcome of HCT, with results presented 
as ORs with 95% CI. A P value of <0.05 was considered statistically significant. 
 
Results 
Patient characteristics 
A total of 106 ILD patients underwent HCT in 3 UK centres. Table 1 demonstrates 
baseline demographic data and diagnostic subgroups of ILD patients. The majority of 
patients were male (70%, n=74), with a mean age of 69.25 years. Mean baseline 
FVC % predicted (76.40  20.73), TLCO (46.89  13.96) and GAP Index of (3.87  
1.47) suggests that the population had at least moderate ILD. Approximately two-
thirds of the group had a MDT consensus diagnosis of IPF (65%, n=69).   
 
Fifty-four (51%) patients failed HCT, of whom 37 (69%) had IPF, and were 
recommended supplemental in-flight oxygen.  
 
Concordance of predictive equations with outcome of actual Hypoxic Challenge 
Testing  
Table 2 demonstrates the sensitivity, specificity, positive and negative predictive 
values of existing predictive equations compared to actual HCT outcomes. Based on 
the availability of complete data required for these equations in 101 patients (n= 51 
Failed HCT, n=50 Passed) and using the previously defined cut-off of PaO2 <6.6kPa, 
predictive equations 2 and 3 were shown to be highly specific (100%); no patient 
who passed HCT was predicted to require supplemental in-flight oxygen using these 
equations. The sensitivity of both equations was poor however, leading to a failure of 
supplemental in-flight oxygen provision to 41 and 47 patients respectively who were 
deemed to need it by HCT. Predictive equation 1 was the most sensitive of the 
models resulting in a failure to provide supplemental in-flight oxygen to only 5 
patients who required it, but resulting in the supply of supplemental in-flight oxygen 
erroneously to an additional 30 patients who passed their HCT.  
 
Comparison of physiological variables and outcome of HCT 
Univariable logistic regression of physiological variables in the cohort of 106 ILD 
patients, revealed that patients who failed HCT (n=54/106) had significantly lower 
resting SpO2, baseline PaO2, reduced walking distance, FEV1, FVC and TLCO, but 
higher GAP index than those who passed HCT (Supplementary Table 2). 
Interestingly, 27.8% of patients with SpO2  96% failed HCT. 
 
Similarly, in the IPF subgroup, patients who failed HCT (n=30/61) had significantly 
lower baseline PaO2, FEV1, FVC and TLCO % predicted, but higher GAP index than 
those who passed HCT. Additionally, the IPF subgroup demonstrated lower 
minimum SpO2 on 6MWT compared to the overall ILD group (Supplementary Table 
3). 
 
Multivariable logistic regression analysis was applied to the results of 86 patients 
with ILD and 49 IPF patients who had complete data sets. Baseline PaO2 was also 
found to be an independent predictor of failing HCT in both ILD patients (n=86) and 
IPF for both groups (Tables 3 and 4). 
 
ROC curve analysis suggested that TLCO % predicted and baseline PaO2 gave the 
highest area under the curve (AUC) values for all variables studied, 0.7343 and 
0.8206 respectively (Figure 1). Using the maximum Youden’s index for each variable, 
FEV1 >85.0% predicted, FVC % predicted >81.50% predicted, TLCO % 
predicted >50% predicted, resting SpO2 >95.5%, GAP index <0.45 and 
6MWT >333.0m were identified as the optimum cut-offs for predicting a ‘Passed 
HCT’ (Supplementary Table 4).  
 
Multivariable logistic regression for passed HCT in ILD patients (n=86 with complete 
data sets) using significant variables from univariable logistic regression and 
optimum cut-offs as determined from ROC curve analysis identified that TLCO >50% 
predicted and baseline Pa02 >9.42 kPa were independently related to the outcome of 
HCT (Table 5). GAP index was excluded from the analysis as 84/86 of the ILD 
patients in this data set had a GAP index of >0.45. 
 
 
ILD pre-flight algorithm 
Based on these analyses a pre-flight algorithm was developed using baseline PaO2 
and TLCO % predicted as key determinants to evaluate whether supplemental in-
flight oxygen was recommended, whether the patient could fly without oxygen or 
whether advice was given for further pre-flight assessment with HCT (Figure 2). This 
algorithm had a sensitivity of 86% and specificity 84% when all patients with 
complete datasets for this information (n=88) were individually tested. Thirty-five 
patients (40%) would have been advised to have pre-flight HCT. Four patients were 
misclassified as not requiring supplemental in-flight oxygen (mean PaO2 10.41kPa  
0.64) and mean TLCO 58.25% predicted  5.32) and 4 patients would have received 
supplemental in-flight oxygen inappropriately (mean PaO2 8.94kPa  0.18 and mean 
TLCO 36.00% predicted  3.56). 
 
 
Discussion  
Large numbers of patients with respiratory disease use commercial air-travel every 
year without adverse effect19, but the potential serious manifestations of hypobaric 
hypoxia are well described5,6 and as such, the BTS recommends risk assessment of 
all ILD patients prior to travel to assess the likelihood of complications and to identify 
those requiring supplemental in-flight oxygen3. Whilst HCT is the method of choice to 
identify those patients in need of supplemental in-flight oxygen8,9, it is not always 
readily available, particularly in primary care. The use of a predictive equation or 
algorithm that may help identify which ILD patients require supplemental in-flight 
oxygen or those that require referral for HCT would be of considerable value in this 
population.  
 
Several predictive equations are available in the published literature but they have 
been developed almost exclusively from patients with COPD and their role in ILD 
has not been fully defined. Our results suggest that although the predictive equations 
tested7,14 would provide a relatively cheap and easily accessible method of 
determining the estimated PaO2 at altitude, they cannot be used in isolation to 
accurately predict the need for supplemental in-flight oxygen in ILD patients. 
Equations 1 and 4, using baseline sea-level PaO2 as the main discriminator, 
overestimated the need for supplemental in-flight oxygen in 30 and 11 patients in our 
cohort respectively. Inclusion of FEV1 measurements (predictive equations 2 and 3), 
as a second discriminator, improved specificity at the expense of sensitivity, failing to 
predict the need for supplemental in-flight oxygen in 41 and 47 patients respectively. 
These findings are consistent with those from small cohorts of ILD patients12,20.  
 
In our cohort, 27.8% patients fulfilled criteria for supplemental in-flight oxygen 
despite SpO2 > 95%. Taken together with the findings from above, our results are 
consistent with previous studies of small cohorts of ILD patients and mixed 
respiratory disease, suggesting that neither resting SpO2 or FEV1 reliably predict 
HCT hypoxaemia3,18,21-25.  
 
According to our results, PaO2 and TLCO (% predicted) independently correlated 
with outcome of HCT in patients with ILD. To the current authors’ knowledge this is 
the largest retrospective multi-centre observational study of ILD patients and the 
physiological parameters that might predict the requirement for supplemental in-flight 
oxygen, as determined by HCT. The present study is also unique in that a well-
defined cohort of 69 IPF patients was examined as part of this study.  
 
It has previously been suggested that a pre-flight Pa02 >9.3kPa is sufficient for air 
travel without the need for supplemental in-flight oxygen26 but several studies have 
subsequently refuted its usefulness in predicting in flight hypoxaemia in COPD 
patients2,27. According to our own results, ILD patients with PaO2 >9.42kPa in 
conjunction with TLCO >50% predicted, can travel safely without supplemental in-
flight oxygen. Conversely, we suggest that patients with PaO2 9.42kPa in 
conjunction with TLCO 50% predicted, require supplemental in-flight oxygen. 
Patients with equivocal results should be referred for HCT prior to travel. Further 
assessment of this algorithm is required in a prospective validation cohort.  
 
An algorithm incorporating pulse oximetry at rest and during 6MWT, was found to be 
a useful tool for discerning COPD patients who can travel without supplemental in-
flight oxygen, those who need supplemental in-flight oxygen and those who require 
further assessment with HCT28. Furthermore, PaO2 during maximal exercise has 
also been strongly correlated with the PaO2 during hypoxic challenge test in cystic 
fibrosis29 and COPD patients21,27. Our results demonstrate that in this ILD cohort 
desaturation during exercise is non-discriminatory, in that 8 (20%) patients who 
passed HCT and 10 (30%) of those who failed HCT desaturated to 84% SaO2 on 
6MWT. This supports the findings of others suggesting that light exercise may 
aggravate hypoxaemia under hypoxic conditions22,28. It is our opinion therefore, that 
further work is required to identify a potential role for exercise testing as part of the 
HCT in patients with ILD.  
 
There are several limitations to the current study, including those inherent to 
retrospective analyses and potential bias related to missing data. The HCT has 
advantages over predictive equations or algorithms in that it also allows 
determination of the flow rate of supplemental in-flight oxygen required. HCT is not 
however an absolute gold standard as it only simulates one aspect of altitude 
exposure, namely the inhalation of a low inspired fraction of oxygen (FiO2) and 
disregards the potential effect of decreased barometric pressure9. Indeed, 
discrepancies between SpO2 obtained during HCT and actual in-flight SpO2 have 
been reported30.  Furthermore, the present authors accept further validation is 
required in a larger prospective cohort of ILD patients.  
 
In summary, the present authors have undertaken the largest retrospective multi-
centre analysis of ILD patients to study the relationship between the development of 
hypoxia during HCT and physiological variables. The correlation between existing 
predictive equations and the actual outcome of HCT was also explored. Existing 
predictive equations are not sufficiently accurate to predict individual hypoxic 
responses during HCT in ILD patients when used in isolation. This is perhaps 
unsurprising given the numerous biological and cellular variables that control oxygen 
homeostasis and the physiological response to hypoxia.  
 
Our findings suggest a correlation between resting PaO2 and TLCO % predicted and 
the outcome of HCT. We propose a novel clinically relevant and practical algorithm 
for assessment of the requirement of supplemental in-flight oxygen in ILD patients 
(Figure 2). This algorithm stratifies ILD patients into those that do /do not require 
supplemental in-flight oxygen and those that require HCT for further assessment. 
This algorithm will require further validation in large prospective ILD cohorts.  
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Figure legends 
Table 1: Demographic data (ILD: Interstitial lung disease, CTD-ILD: Connective 
tissue disease related ILD, CPFE: Combined Pulmonary Fibrosis and Emphysema, 
COP: Cryptogenic Organising Pneumonia). 
 
Table 2: Sensitivity and specificity of predictive equations in determining the need for 
supplemental in-flight oxygen compared to actual HCT results with calculated 
positive (PPV) and negative predictive values (NPV) in a) ILD patients b) IPF 
subgroup. 
 
Figure 1: Receiver operating characteristics (ROC) curve analysis of physiological 
variables for the outcome of HCT. A) FEV1 % predicted, B) FVC % predicted, C) 
TLCO % predicted, D) baseline PaO2 (kPa), E) Resting SaO2 (%) and F) GAP index. 
AUC = area under the curve. 
Table 3: Multivariable logistic regression for failed HCT test in ILD (only patients with 
complete data sets used n=86). 6MWT variables not included as large number of 
patients had missing data for this variable. P value = significance level, CI = 
confidence interval.  
 
Table 4: Multivariable logistic regression for failed HCT in IPF (n=49 patients with 
complete data). 6MWT variables not included as large number of patients had 
missing data for this variable. P value = significance level, CI = confidence interval.  
 
Table 5: Multivariable logistic regression for passed HCT in ILD patients (n=86 with 
complete data sets) using significant variables from univariable logistic regression 
and optimum cut-offs as determined from ROC curve analysis.  
Figure 2: ILD pre-flight algorithm. ILD patients with PaO2 >9.42kPa in conjunction 
with TLCO >50% predicted can travel safely without supplemental in-flight oxygen. 
Patients with PaO2 9.42kPa in conjunction with TLCO 50% predicted require 
supplemental in-flight oxygen. Patients with equivocal results should be referred for 
further assessment with HCT prior to travel. ILD- Interstitial lung disease, PaO2 – 
partial pressure of oxygen, TLCO – transfer factor for carbon monoxide, kPa – kilo 
pascals.   
 
 
 
 Mean  S.D. n 
Age (years) 69.25    8.85 106 
Gender 74M: 32F - 
FEV1 (litres) 2.05    0.62 105 
FEV1 % predicted 78.22    19.47 105 
FVC (litres) 2.52    0.79 106 
FVC % predicted 76.40    20.73 106 
FEV1/FVC 81.21    6.96 105 
TLCO 3.78    1.31 93 
TLCO % predicted 46.89    13.96 93 
KCO 1.10    0.33 92 
KCO % predicted 83.02    23.03 92 
Baseline PaO2 (kPa) 9.34    1.41 101 
Resting SpO2 (%) 94.79    2.85 105 
GAP index 3.87   1.47 101 
6MWT 
-actual distance (m) 
-%theoretical distance (%) 
-minimum SpO2 (%) 
-maximum heart rate (bpm) 
 
339.51    103.77 
70.56    2.32 
86.80    5.44 
111.71    15.24 
 
73 
71 
73 
47 
Diagnoses 
-Idiopathic Pulmonary Fibrosis 
-Non-specific interstitial 
pneumonia 
-CTD-ILD 
-Sarcoidosis 
-Hypersensitivity pneumonitis 
-CPFE 
-Asbestosis 
-Drug induced ILD 
-COP 
-Smoking related ILD 
-Unclassifiable ILD 
 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 
69 
9 
9 
3 
6 
3 
1 
1 
1 
1 
3 
 
 
Table 1: Demographic data (ILD: Interstitial lung disease, CTD-ILD: Connective 
tissue disease related ILD, CPFE: Combined Pulmonary Fibrosis and Emphysema, 
COP: Cryptogenic Organising Pneumonia). 
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Table 2: Sensitivity and specificity of predictive equations in determining the need for 
supplemental in-flight oxygen compared to actual HCT results with calculated 
positive (PPV) and negative predictive values (NPV) in a) ILD patients b) IPF 
subgroup. 
 
 
 
 
a) ILD Patients     
Predictive 
equation 
Sensitivity % Specificity % PPV % NPV % 
Equation 1 90  60 70 86 
Equation 2 20 100 100 55 
Equation 3   8 100 100 52 
Equation 4 75   78 78 75 
b) IPF Patients     
Predictive 
equation  
Sensitivity % Specificity % PPV % NPV % 
Equation 1 92  59 63 81 
Equation 2 19 100 100 52 
Equation 3   8 100 100 49 
Equation 4 78   78 80 76 
Table 2
 Odds 
ratio 
p value 95% CI 
FEV1 % predicted 0.937 0.151 0.857 to 1.024 
FVC % predicted 1.044 0.291 0.964 to 1.132 
TLCO % predicted 0.915 0.130 0.816 to 1.299 
KCO predicted 0.987 0.671 1.048 to 2.074 
Baseline PaO2 (kPa) 0.205 <0.001 0.090 to 0.471 
Resting SpO2 (%) 0.866 0.299 0.880 to 1.513 
GAP Index 0.974 0.958 0.387 to 2.718 
 
 
Table 3: Multivariable logistic regression for failed HCT test in ILD (only patients with 
complete data sets used n=86). 6MWT variables not included as large number of 
patients had missing data for this variable. P value = significance level, CI = 
confidence interval.  
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Table 4: Multivariable logistic regression for failed HCT in IPF (n=49 patients with 
complete data). 6MWT variables not included as large number of patients had 
missing data for this variable. P value = significance level, CI = confidence interval.  
 
 Odds 
Ratio 
P value 95% CI  
FEV1 % predicted 0.950 0.425 0.837 to 1.078 
FVC % predicted 1.000 0.982 0.878 to 1.136 
TLCO % predicted 0.897 0.240 0.749 to 1.075 
KCO predicted 1.018 0.739 0.916 to 1.131 
Baseline PaO2 (kPa) 0.165 0.003 0.749 to 1.075 
Resting SpO2 (%) 0.823 0.484 0.476 to 1.420 
GAP index  0.446 0.251 0.112 to 1.771 
Table 4
  Odds 
Ratio 
p value 95% CI 
FEV1 % predicted 
>85.0 
1.004 0.995 0.247 to 4.091 
FVC % predicted 
>81.5 
2.667 0.175 0.646 to 11.013 
TLCO % predicted 
>50.5 
3.481 0.025 1.170 to 10.353 
Baseline PaO2 (kPa) 
>9.42 
8.331 <0.001  2.547 to 27.253 
Resting SpO2 (%) 
>95.5 
1.040 0.945 0.338 to 3.204 
 
 
 
 
Table 5: Multivariable logistic regression for passed HCT in ILD patients (n=86 with 
complete data sets) using significant variables from univariable logistic regression 
and optimum cut-offs as determined from ROC curve analysis.  
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